Abiopharma

New Form SCHEDULE 13G - TANDEM DIABETES CARE INC Filed: 2025-05-15 AccNo: 0001398344-25-009644 Size: 13 KB

Agilent Technologies, Inc. - Agilent to Participate in Jefferies Global Healthcare Conference

New Form 424B3 - Autolus Therapeutics plc Filed: 2025-05-15 AccNo: 0001193125-25-120811 Size: 274 KB

New Form SCHEDULE 13G/A - uniQure N.V. Filed: 2025-05-15 AccNo: 0000902664-25-002395 Size: 10 KB

New Form SCHEDULE 13G/A - Checkpoint Therapeutics, Inc. Filed: 2025-05-15 AccNo: 0001076809-25-000050 Size: 8 KB

Agilent to Participate in Jefferies Global Healthcare Conference

New Form 8-K - Immunocore Holdings plc Filed: 2025-05-15 AccNo: 0001140361-25-019282 Size: 249 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form 8-K - Zomedica Corp. Filed: 2025-05-15 AccNo: 0001654954-25-005749 Size: 204 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form SCHEDULE 13G/A - Solid Biosciences Inc. Filed: 2025-05-15 AccNo: 0000902664-25-002394 Size: 10 KB

New Form 8-K - Sensus Healthcare, Inc. Filed: 2025-05-15 AccNo: 0001753926-25-000851 Size: 315 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form 5 - IGC Pharma, Inc. Filed: 2025-05-15 AccNo: 0001185185-25-000496 Size: 14 KB

New Form SCHEDULE 13G/A - Nyxoah SA Filed: 2025-05-15 AccNo: 0000902664-25-002393 Size: 10 KB

Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025 and Provide Business Update on Thursday, May 29, 2025

New Form SCHEDULE 13G/A - Fortrea Holdings Inc. Filed: 2025-05-15 AccNo: 0000010742-25-000009 Size: 6 KB

New Form SCHEDULE 13G/A - Definitive Healthcare Corp. Filed: 2025-05-15 AccNo: 0001415889-25-013098 Size: 8 KB